NCT02161692View on ClinicalTrials.gov

Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1996

Primary Completion Date

May 31, 2007

Study Completion Date

April 30, 2009

Conditions
Testicular NeoplasmsGerm Cell Tumors
Interventions
DRUG

Cyclophosphamide

DRUG

Etoposide

DRUG

Cisplatin

DRUG

Bleomycin

DRUG

Carboplatin

High dose carboplatin

Trial Locations (1)

20133

Istituto Nazionale dei Tumori, Milan

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT02161692 - Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | Biotech Hunter | Biotech Hunter